Cargando…

The Connected Community Pharmacy: Benefits for Healthcare and Implications for Health Policy

The need for interoperability of healthcare Information Technology (IT) systems in order to provide safe, efficient, and coordinated healthcare is universally recognized. Various health economies, such as the United Kingdom, the United States, and Australia, are seeking to develop regional, state-wi...

Descripción completa

Detalles Bibliográficos
Autor principal: Goundrey-Smith, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279871/
https://www.ncbi.nlm.nih.gov/pubmed/30546307
http://dx.doi.org/10.3389/fphar.2018.01352
_version_ 1783378557167206400
author Goundrey-Smith, Stephen
author_facet Goundrey-Smith, Stephen
author_sort Goundrey-Smith, Stephen
collection PubMed
description The need for interoperability of healthcare Information Technology (IT) systems in order to provide safe, efficient, and coordinated healthcare is universally recognized. Various health economies, such as the United Kingdom, the United States, and Australia, are seeking to develop regional, state-wide, or national systems of healthcare interoperability. In England, the community pharmacy network is a significant health provider, with important implications for provision of healthcare in deprived areas because of its accessibility. Historically, however, community pharmacies have operated on a silo basis, and have not shared information on their activities with, or been able to access information from, other National Health Service (NHS) healthcare providers. The development of services such as the Electronic Prescription Service and the Summary Care Record in England have helped to connect community pharmacy with the NHS infrastructure, and more comprehensive systems and datasets are proposed to integrate community pharmacy with the NHS in future. This paper will review the benefits of the connected community pharmacy, based on developments to date and reviewing evidence from other countries. It will describe some of the future developments that will support the connected community pharmacy in England, and discuss some of the implications for pharmacists and health policy makers.
format Online
Article
Text
id pubmed-6279871
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-62798712018-12-13 The Connected Community Pharmacy: Benefits for Healthcare and Implications for Health Policy Goundrey-Smith, Stephen Front Pharmacol Pharmacology The need for interoperability of healthcare Information Technology (IT) systems in order to provide safe, efficient, and coordinated healthcare is universally recognized. Various health economies, such as the United Kingdom, the United States, and Australia, are seeking to develop regional, state-wide, or national systems of healthcare interoperability. In England, the community pharmacy network is a significant health provider, with important implications for provision of healthcare in deprived areas because of its accessibility. Historically, however, community pharmacies have operated on a silo basis, and have not shared information on their activities with, or been able to access information from, other National Health Service (NHS) healthcare providers. The development of services such as the Electronic Prescription Service and the Summary Care Record in England have helped to connect community pharmacy with the NHS infrastructure, and more comprehensive systems and datasets are proposed to integrate community pharmacy with the NHS in future. This paper will review the benefits of the connected community pharmacy, based on developments to date and reviewing evidence from other countries. It will describe some of the future developments that will support the connected community pharmacy in England, and discuss some of the implications for pharmacists and health policy makers. Frontiers Media S.A. 2018-11-28 /pmc/articles/PMC6279871/ /pubmed/30546307 http://dx.doi.org/10.3389/fphar.2018.01352 Text en Copyright © 2018 Goundrey-Smith. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Goundrey-Smith, Stephen
The Connected Community Pharmacy: Benefits for Healthcare and Implications for Health Policy
title The Connected Community Pharmacy: Benefits for Healthcare and Implications for Health Policy
title_full The Connected Community Pharmacy: Benefits for Healthcare and Implications for Health Policy
title_fullStr The Connected Community Pharmacy: Benefits for Healthcare and Implications for Health Policy
title_full_unstemmed The Connected Community Pharmacy: Benefits for Healthcare and Implications for Health Policy
title_short The Connected Community Pharmacy: Benefits for Healthcare and Implications for Health Policy
title_sort connected community pharmacy: benefits for healthcare and implications for health policy
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279871/
https://www.ncbi.nlm.nih.gov/pubmed/30546307
http://dx.doi.org/10.3389/fphar.2018.01352
work_keys_str_mv AT goundreysmithstephen theconnectedcommunitypharmacybenefitsforhealthcareandimplicationsforhealthpolicy
AT goundreysmithstephen connectedcommunitypharmacybenefitsforhealthcareandimplicationsforhealthpolicy